-
2024/10/11
採用情報
現在，本研究所では下記の職員を公募しています。 人獣共通感染症国際共同研究所 事務補佐員 １名 応募締切日 採用者決定次第終了 詳細を見る…
-
2024/08/22
【Press release】Approval for the Ebola virus disease rapid diagnostic kit in the Democratic Republic of the Congo
The QuickNavi–Ebola rapid diagnostic kit for Ebola virus disease, developed in collaboration with Denka Company Limited,…
-
2024/01/9
Dr. Sasaki who is Lecturer in our institute received the 2023 Hokkaido Science and Technology Encouragement Award.
The Hokkaido Government presents the Hokkaido Science and Technology Award as a governor's commendation to those who hav…
-
2023/12/1
Application is now open for two associate professors.
The following positions are now open. - two associate professors For more information, see the other page. …
-
2023/09/7
Announcement of the 11th Meeting of the Consortium for the Control of Zoonoses
We are delighted to invite you to the 11th Meeting of the Consortium for the Control of Zoonoses to be held on 25th and …
-
2023/05/22
Professor Sawa received the title of Hokkaido University Distinguished Professor.
Prof. Sawa was bestowed the title of Hokkaido University Distinguished Professor in April, 2023. He received the award…
-
2022/12/9
Approach to the development of Xocova was introduced in the University News on Hokkaido University's official website.
Shionogi & Co., Ltd and our institute's approach to the development of Xocova approved in November, was introduced i…
-
2022/12/1
Lecturer, Dr. Matsuno and assistant professor, Dr. Kajihara were appointed as associate professors.
Lecturer, Dr. Keita Matsuno in the division of risk analysis and management, and assistance professor, Dr. Kajihara in t…
-
2022/10/21
Professor Suzuki received an honorary doctorate of Mahidol University, Thailand from Her Royal Highness Princess Maha Chakri Sirindhorn of Thailand.
Professor Suzuki received an honorary doctorate of Mahidol University, Thailand from Her Royal Highness Princess Maha Ch…
-
2022/05/13
The article published on the J Med Chem was introduced as the most read articles for the previous 30 days.
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19 &n…